$1.18
▼ -5.6% Today
as of Oct 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
BNGO earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±3.1% on average; after the most recent report on May 13, 2026 it moved -0.8%. BNGO beat the consensus EPS estimate in 4 of its last 4 reported quarters. The share price of $1.18 sits near its 52-week low.
Overview
52-week range
$1.00
$2.23
15% of range
Avg surprise (last 4)
+27.8%
Avg reaction (last 2)
-3.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.64 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.76 | $-0.81 | +6.2% | +33.9% | -0.8% | earnings |
| Thu Nov 13, 2025 | Sep/2025 | $-1.59 | $-1.81 | +12.2% | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-1.99 | $-2.69 | +26.0% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-1.15 | $-3.49 | +67.0% | — | -5.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-30.92 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-14.41 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-35.75 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-3.22 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.24 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.23 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $7M | — | $7M | $7M | $6M | — | $6M |
| Cost of revenue | $4M | $3M | — | $4M | $3M | $4M | — | $15M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-7M | $-8M | — | $-9M | $-8M | $-8M | — | $-44M |
| Net income | $-7M | $-8M | — | $-9M | $-7M | $-3M | — | $-44M |
| EPS (diluted) | $-0.64 | $-0.76 | — | $-1.59 | $-1.99 | $-1.15 | — | $-30.92 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $3M | $3M | $3M | $4M | $4M | $9M | $9M |
| Inventory | $7M | $8M | $8M | $8M | $10M | $11M | $13M | $16M |
| Total current assets | $25M | $39M | $45M | $49M | $43M | $45M | $39M | $47M |
| Total assets | $48M | $65M | $74M | $79M | $76M | $78M | $77M | $87M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $16M | $27M | $29M | $29M | $31M | $30M | $41M | $38M |
| Total equity | $32M | $37M | $44M | $50M | $45M | $48M | $35M | $49M |
Implied volatility — last 90 days
No IV snapshots yet for BNGO.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
BNGO earnings FAQ
How does BNGO stock usually react to earnings?
Across the last 2 reports the average next-day move was ±3.1%, up 0 times and down 2 times.